Metraipolis › archive › dc_52f6de43ff4a

Tailoring Anticoagulant Therapy: Managing Interactions Between Carbamazepine and Direct Oral Anticoagulants (DOACs) — Europe PMC PMID:41209961

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41209961
DOI
10.7759/cureus.93905
License (as archived)
solo-consultazione
Archived
2026-11-09T13:51:31.834Z
SHA-256 of the archived text
48d6b32cf2cf0def1119d2c6de4164968b56eb3acc4c5d2bd29a844f40ec1b90
Stable URL of this page
https://metraipolis.com/documento/dc_52f6de43ff4a

How to cite

Tailoring Anticoagulant Therapy: Managing Interactions Between Carbamazepine and Direct Oral Anticoagulants (DOACs) — Europe PMC PMID:41209961 — Europe PMC (en), https://europepmc.org/article/MED/41209961 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_52f6de43ff4a (Metraipolis archive dc_52f6de43ff4a, sha256 48d6b32cf2cf0def1119d2c6de4164968b56eb3acc4c5d2bd29a844f40ec1b90)
BibTeX
@misc{dc52f6de43ff4a,
  title = {Tailoring Anticoagulant Therapy: Managing Interactions Between Carbamazepine and Direct Oral Anticoagulants (DOACs) — Europe PMC PMID:41209961},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41209961},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_52f6de43ff4a; sha256 48d6b32cf2cf0def1119d2c6de4164968b56eb3acc4c5d2bd29a844f40ec1b90},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41209961. Agents can read the archived copy with the MCP tool read_document.